The Top 10 Things You Need to Know About ADNCA Datasets Guide The Top 10 Things You Need to Know About ADNCA Datasets Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…CertaraSeptember 11, 2025
Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit –CertaraSeptember 5, 2025
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…CertaraSeptember 5, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar On-Demand Webinar The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…CertaraAugust 18, 2025
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Case Study Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…CertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025
Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Blog Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…CertaraAugust 6, 2025